Combination Therapy of Ledipasvir and Itraconazole in the Treatment of COVID-19 Patients Coinfected with Black Fungus: An <i>In Silico</i> Statement

<div>Binding interactions of ledipasvir (a) and (b), elbasvir (c) and (d), and pibrentasvir (e) and (f) with SARS-CoV-2 spike glycoprotein (PDB 7NEH).</div>

BioMed Research International

fig3

Figure 3

Figure 3: Combination Therapy of Ledipasvir and Itraconazole in the Treatment of COVID-19 Patients Coinfected with Black Fungus: An <i>In Silico</i> Statement 

Figure 3 | Combination Therapy of Ledipasvir and Itraconazole in the Treatment of COVID-19 Patients Coinfected with Black Fungus: An In Silico Statement 